As an associate physician in the Section of Emergency Critical Care, Department of Emergency Medicine, Brigham and Women’s Hospital (BWH), Peter Hou is dual boarded in emergency medicine and critical care medicine and practices clinically in both the emergency department (ED) and surgical intensive care unit (ICU). His interests consist of patient care and disease processes that transcend from the ED to the ICU. As for his research interests, he participated as site principal investigator (PI) for the “Protocolized Care for Early Septic Shock” trial to evaluate the role of protocolized, quantitative resuscitation treatments in the management of severe sepsis and septic shock. In the surgical ICU, he participated as site-PI for the US Critical Illness and Injury Trial Group Lung Injury Prevention Study (USCIITG-LIPS) that derived and validated the Lung Injury Prediction Score (LIPS) in patients at risk for ARDS. Currently, he is the site-PI for the National Institute of Health (NIH) Lung Injury Prevention Study with Aspirin and a Co-PI for the National Heart Lung Blood Institute (NHLBI) Acute Lung Injury of New England Clinical Center (ALIGNE) and serves on the Steering Committee for the NHLBI Prevention and Early Treatment of Acute Lung injury (PETAL) Network (http://petalnet.org/).